JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB206926

Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Recombinant Monoclonal Progesterone Receptor antibody. Carrier free. Suitable for IHC-P, ICC/IF, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications.

View Alternative Names

NR3C3, PGR, Progesterone receptor, PR, Nuclear receptor subfamily 3 group C member 3

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32085).

Immunofluorescence staining of Recombinant Anti-Progesterone Receptor antibody [YR85] (ab32085) in T47D cells (+ve control) and HepG2 cells (-ve control). The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab32085 at 0.2 μg/mL dilution and ab7291, Anti-alpha Tubulin antibody [DM1A], at 1/1000 dilution, followed by a further incubation at room temperature for 1h with Goat Anti-Rabbit IgG H&L (Alexa Fluor® 647) preadsorbed (ab150087) at 1/1000 (shown in red) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed (ab150117) at 1/1000 (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with the Perkin Elmer Operetta and a maximum intensity projection of confocal planes is shown.

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32085).

Immunofluorescence staining of Recombinant Anti-Progesterone Receptor antibody [YR85] (ab32085) in T47D cells (+ve control) and HepG2 cells (-ve control). The cells were fixed with 100% Methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab32085 at 0.2 μg/mL dilution and ab7291, Anti-alpha Tubulin antibody [DM1A], at 1/1000 dilution, followed by a further incubation at room temperature for 1h with Goat Anti-Rabbit IgG H&L (Alexa Fluor® 647) preadsorbed (ab150087) at 1/1000 (shown in red) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed (ab150117) at 1/1000 (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with the Perkin Elmer Operetta and a maximum intensity projection of confocal planes is shown.

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

ICC/IF image of ab32085 stained DU145 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab32085 at 5µg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32085).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

Immunohistochemical analysis of progesterone receptor expression in paraffin embedded human breast carcinoma, using 1/100 ab32085.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32085).

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Flow Cytometry (Intracellular) - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

Intracellular Flow Cytometry analysis of T47D (human mammary gland ductal carcinoma) cells labeling Progesterone Receptor with purified ab32085 at 1/1100 dilution (1ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488) (ab150077) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) (ab172730) was used as the isotype control, Cell without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32085).

Western blot - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • WB

Unknown

Western blot - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32085). Blocking buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Progesterone Receptor antibody [YR85] (<a href='/en-us/products/primary-antibodies/progesterone-receptor-antibody-yr85-ab32085'>ab32085</a>) at 1/2000 dilution

All lanes:

T-47D (Human ductal breast epithelial tumor epithelial cell) whole cell lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 98 kDa

Observed band size: 118 kDa

false

Exposure time: 40s

Western blot - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • WB

Unknown

Western blot - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32085).

All lanes:

Western blot - Anti-Progesterone Receptor antibody [YR85] (<a href='/en-us/products/primary-antibodies/progesterone-receptor-antibody-yr85-ab32085'>ab32085</a>) at 1/1000 dilution

All lanes:

Human breast cancer lysate at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/20000 dilution

Predicted band size: 98 kDa

Observed band size: 118 kDa

false

Exposure time: 180s

OI-RD Scanning - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free (AB206926)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Unconjugated

    Anti-Progesterone Receptor antibody [YR85]

  • 660 APC

    APC Anti-Progesterone Receptor antibody [YR85]

  • 578 PE

    PE Anti-Progesterone Receptor antibody [YR85]

  • HRP

    HRP Anti-Progesterone Receptor antibody [YR85]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Progesterone Receptor antibody [YR85]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Progesterone Receptor antibody [YR85]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Progesterone Receptor antibody [YR85]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-Progesterone Receptor antibody [YR85]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Progesterone Receptor antibody [YR85]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

YR85

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

WB, IHC-P, Flow Cyt (Intra), ICC/IF, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody recognises progesterone receptor. The antibody does not cross-react with other NR3 family members. Since the recognized epitope is near the N-terminal end of the protein, this product should only detect isoform B and not isoform A.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>Please check the parent abID, <a href='/en-us/products/primary-antibodies/progesterone-receptor-antibody-yr85-ab32085'>ab32085</a>, for more information on dilutions.</p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" } } }

Product details

ab206926 is the carrier-free version of ab32085.

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The progesterone receptor (PR) also known as NR3C3 is a nuclear receptor that functions as a transcription factor in response to the hormone progesterone. This receptor has a mass of approximately 99 kDa and is expressed in tissues such as the reproductive organs including the uterus ovaries and mammary glands. It is also found in non-reproductive tissues like the brain and bone. The receptor has two main isoforms PR-A and PR-B which differ slightly in structure but have unique biological roles.
Biological function summary

The progesterone receptor plays a significant role in regulating gene expression related to reproductive processes. PR is not part of a larger complex by itself but interacts with various coactivators and corepressors to modulate transcription. In the uterus and mammary glands PR mediates the effects of progesterone by promoting cell proliferation and preparing tissues for pregnancy. In other systems PR also links to various metabolic and immunological pathways influencing cell cycle progression and immune response.

Pathways

Progesterone receptor activity is integrated within the reproductive hormone signaling pathways and the Wnt signaling pathway. The receptor interacts directly with key proteins such as estrogen receptor (ER) and steroid receptor coactivator (SRC) complexes which are pivotal in modulating response to hormonal signals. These interactions underline the essential role of PR in maintaining hormonal balance and regulating reproductive functions.

The progesterone receptor associates with breast cancer and endometriosis. Aberrant expression or mutations in PR can contribute to the development and progression of breast cancer often linked with the estrogen receptor's influence. In endometriosis PR's altered functionality affects cellular response to progesterone contributing to tissue growth outside the uterus. These conditions also involve interactions with proteins like BRCA1 in breast cancer highlighting how PR connects to broader cellular and pathological networks.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as a transcriptional activator or repressor.. Isoform A. Ligand-dependent transdominant repressor of steroid hormone receptor transcriptional activity including repression of its isoform B, MR and ER. Transrepressional activity may involve recruitment of corepressor NCOR2.. Isoform B. Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation.. Isoform 4. Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
See full target information PGR

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 9:185 PubMed37344459

2023

TRPS1 regulates the opposite effect of progesterone via RANKL in endometrial carcinoma and breast carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Linlin Yang,Qiong Fan,Jing Wang,Xiaoming Yang,Jiangjing Yuan,Yuhong Li,Xiao Sun,Yudong Wang

Cancers 15: PubMed36765785

2023

Flexible Cyclic Immunofluorescence (cyCIF) Using Oligonucleotide Barcoded Antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Nathan P McMahon,Jocelyn A Jones,Ashley N Anderson,Matthew S Dietz,Melissa H Wong,Summer L Gibbs

International journal of molecular sciences 23: PubMed36233194

2022

Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Yu Deng,He Huang,Jiangcheng Shi,Hongyan Jin

Gynecologic oncology 131:368-73 PubMed23911795

2013

Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer.

Applications

ICC/IF

Species

Human

Peter A Argenta,Inhwa Um,Charlene Kay,David Harrison,Dana Faratian,Thanasak Sueblinvong,Melissa A Geller,Simon P Langdon

Proceedings of the National Academy of Sciences of 108:18879-86 PubMed22011582

2011

Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Applications

WB

Species

Human

Eric A Ariazi,Heather E Cunliffe,Joan S Lewis-Wambi,Michael J Slifker,Amanda L Willis,Pilar Ramos,Coya Tapia,Helen R Kim,Smitha Yerrum,Catherine G N Sharma,Emmanuelle Nicolas,Yoganand Balagurunathan,Eric A Ross,V Craig Jordan

Clinical proteomics 6:129-51 PubMed21691416

2011

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.

Applications

Dot

Species

Human

Bryan T Hennessy,Yiling Lu,Ana Maria Gonzalez-Angulo,Mark S Carey,Simen Myhre,Zhenlin Ju,Michael A Davies,Wenbin Liu,Kevin Coombes,Funda Meric-Bernstam,Isabelle Bedrosian,Mollianne McGahren,Roshan Agarwal,Fan Zhang,Jens Overgaard,Jan Alsner,Richard M Neve,Wen-Lin Kuo,Joe W Gray,Anne-Lise Borresen-Dale,Gordon B Mills

BMC cancer 11:207 PubMed21619605

2011

Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression.

Applications

WB

Species

Unspecified reactive species

Chelsea R Tieszen,Alicia A Goyeneche,BreeAnn N Brandhagen,Casey T Ortbahn,Carlos M Telleria

Cancer research 69:4116-24 PubMed19435916

2009

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

Applications

Unspecified application

Species

Unspecified reactive species

Bryan T Hennessy,Ana-Maria Gonzalez-Angulo,Katherine Stemke-Hale,Michael Z Gilcrease,Savitri Krishnamurthy,Ju-Seog Lee,Jane Fridlyand,Aysegul Sahin,Roshan Agarwal,Corwin Joy,Wenbin Liu,David Stivers,Keith Baggerly,Mark Carey,Ana Lluch,Carlos Monteagudo,Xiaping He,Victor Weigman,Cheng Fan,Juan Palazzo,Gabriel N Hortobagyi,Laura K Nolden,Nicholas J Wang,Vicente Valero,Joe W Gray,Charles M Perou,Gordon B Mills

Cancer prevention research (Philadelphia, Pa.) 1:577-87 PubMed19139008

2009

A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Woo-Young Kim,Dong Jo Chang,Bryan Hennessy,Hae Jin Kang,Jakyung Yoo,Seung-Ho Han,Yoo-Shin Kim,Hyun-Ju Park,Seung-Yong Seo,Seung-Yong Geo,Gordon Mills,Kyu-Won Kim,Waun Ki Hong,Young-Ger Suh,Ho-Young Lee

The Journal of clinical endocrinology and metaboli 92:4459-66 PubMed17785366

2007

Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ping Yin,Zhihong Lin,You-Hong Cheng,Erica E Marsh,Hiroki Utsunomiya,Hiroshi Ishikawa,Qing Xue,Scott Reierstad,Joy Innes,Stephen Thung,J Julie Kim,Eugene Xu,Serdar E Bulun
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com